Powered by
-
EW Stock Chart
Historical EW Prices
Edwards Lifesciences Stock Analysis
Rating: Buy
Total Grade: B
Analysis Breakdown
| EW Stock Grade: | B |
| Fundamental Grade: | C |
| Quantitative Grade: | A |
| EW Earnings | |
| Earnings Growth: | D |
| Earnings Momentum: | F |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | B |
| EW Financial Information | |
| Sales Growth: | B |
| Operating Margin Growth: | D |
| Cash Flow: | D |
| Return on Equity: | A |
Edwards Lifesciences Stock: Weekly View
| This Week: | B |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |
EW Stock predictions, Articles, and Edwards Lifesciences News
- From InvestorPlace
- From the Web
-
7 Rock-Solid Stocks to Hold On for Dear Life - February 12, 2018
In such fragile market conditions, it pays to keep your portfolio full of solid stocks with consistent growth and a favorable outlook. All of the seven stocks to buy in this article are up on a one-month basis. Some of them by over 10%! Continue…
-
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Edwards Lifesciences Corp (EW) and Motorola Solutions Inc (MSI) - February 2, 2018
Amgen (AMGN) posted underwhelming earnings, Edwards Lifesciences (EW) posts strong 2017 revenue and Motorola Solutions (MSI) expects 2018 EPS to beat estimates. Continue…
-
The 10 Most Expensive Stocks In The S&P 500 - January 24, 2018
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware. Continue…
-
Edwards Lifesciences (EW) Ranking Raised to Buy on Robust Earnings Growth - December 12, 2017
Edwards Lifesciences (NYSE:EW) is ranked as a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week. Continue…
-
Edwards Lifesciences (EW) Upgraded to Buy on Improving Sales Growth - December 5, 2017
Portfolio Grader currently ranks Edwards Lifesciences (NYSE:EW) a Buy. The approach to fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week. EW has been upgraded from a Hold to a Buy in the last week. Continue…
-
Industry Group Rank Metrics Limit Edwards Lifesciences (EW) Ratings Upgrade to Hold - November 7, 2017
With a $21.7 billion market value, Edwards Lifesciences (NYSE:EW) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for EW by Portfolio Grader places it 76 among the 164 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 366 among the 785 companies in the sector, and number 2,386 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day - September 27, 2017
With World Heart Day coming up, here is a look at some well-positioned stocks including BioTelemetry (BEAT) in this segment of the market. Continue…
-
7 ‘Strong Buy’ Stocks Wall Street Is 100% Sure Of - September 22, 2017
With stocks to buy, a consensus on the Street is hard to beat. Here are 7 'Strong Buy' stocks that have the complete support of the Street. Continue…
-
7 Sectors, 7 Top Stocks Poised to Take Off - July 31, 2017
We set out to find the best stock in each sector, using a stock screener to pull up only stocks with a "strong buy" analyst consensus rating. Continue…
-
The 7 Best Low-Risk Healthcare Stocks to Buy - March 22, 2017
The best healthcare stocks to buy now are those that are safe no matter when the American Health Care Act is passed, or what it looks like. Continue…
